<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.12.0">
<page number="1" position="absolute" top="0" left="0" height="790" width="595">
	<fontspec id="0" size="10" family="MKPLOD+BrybpxAdvTT86d47313" color="#131413"/>
	<fontspec id="1" size="10" family="MKPMBF+LgpcxwAdvTT8861b38f.I" color="#131413"/>
	<fontspec id="2" size="10" family="MKPKJE+TqyqdlAdvTTaf7f9f4f.B" color="#131413"/>
	<fontspec id="3" size="8" family="MKPKJE+TqyqdlAdvTTaf7f9f4f.B" color="#131413"/>
	<fontspec id="4" size="8" family="MKPKNE+BxtlhnAdvTTb5929f4c" color="#131413"/>
	<fontspec id="5" size="8" family="MKPKND+VktbsgAdvTTe45e47d2" color="#131413"/>
	<fontspec id="6" size="8" family="MKPLMC+ShjqhmAdvTT7329fd89.I" color="#131413"/>
	<fontspec id="7" size="8" family="MyriadPro" color="#131413"/>
<text top="376" left="57" width="234" height="9" font="0">localized infratentorially with nonhomogeneous en-</text>
<text top="388" left="57" width="234" height="9" font="0">hancement (Fig. <a href="">7). </a>In the second exceptional case, a</text>
<text top="400" left="57" width="234" height="9" font="0">non-enhancing supratentorial lesion was present sus-</text>
<text top="412" left="57" width="234" height="9" font="0">pected to be low-grade glioma; however, histology con-</text>
<text top="424" left="57" width="197" height="9" font="0">firmed the diagnosis of GBM (WHO Grade IV).</text>
<text top="436" left="65" width="226" height="9" font="0">Several significant differences between both brain infil-</text>
<text top="448" left="57" width="234" height="9" font="0">trative tumors were found (see Table <a href="">3). </a>Notably, no</text>
<text top="460" left="57" width="234" height="9" font="0">homogenous enhancement was found in GBM, in con-</text>
<text top="472" left="57" width="234" height="9" font="0">trast to homogeneous enhancement detected in 64.8% of</text>
<text top="484" left="57" width="71" height="9" font="0">PCNSL lesions (</text>
<text top="482" left="128" width="5" height="13" font="1">p</text>
<text top="484" left="135" width="156" height="9" font="0">&lt; 0.001). Enhancement in GBM was</text>
<text top="496" left="57" width="234" height="9" font="0">nonhomogeneous in 98.1% of cases (no enhancement in</text>
<text top="508" left="57" width="234" height="9" font="0">1 case) and necrosis was present in 88.9% of cases. Con-</text>
<text top="520" left="57" width="234" height="9" font="0">versely, necrosis was present only in 5.6% of PCNSL</text>
<text top="532" left="57" width="234" height="9" font="0">cases and nonhomogeneous enhancement in 14.8% of</text>
<text top="544" left="57" width="80" height="9" font="0">PCNSL cases (both</text>
<text top="542" left="140" width="5" height="13" font="1">p</text>
<text top="544" left="147" width="144" height="9" font="0">&lt; 0.001). Diffuse infiltrative type of</text>
<text top="556" left="57" width="234" height="9" font="0">brain involvement was observed only in PCNSL (24.1%</text>
<text top="568" left="57" width="234" height="9" font="0">of cases). Additionally, optic pathways infiltration was</text>
<text top="580" left="57" width="192" height="9" font="0">more frequent in PCNSL than in GBM (</text>
<text top="578" left="249" width="5" height="13" font="1">p</text>
<text top="580" left="256" width="34" height="9" font="0">&lt; 0.001);</text>
<text top="592" left="57" width="234" height="9" font="0">present in 42.6% of PCNSL cases and only in 5.6% of</text>
<text top="604" left="57" width="234" height="9" font="0">GBM cases. Signs of bleeding were more common in</text>
<text top="616" left="57" width="141" height="9" font="0">GBM (44.4%) than PCNSL (5.6%);</text>
<text top="614" left="201" width="5" height="13" font="1">p</text>
<text top="616" left="208" width="83" height="9" font="0">&lt; 0.001. Both supra-</text>
<text top="628" left="57" width="234" height="9" font="0">tentorial and infratentorial localization was present only</text>
<text top="640" left="57" width="234" height="9" font="0">in PCNSL (27.7%). The basal ganglia were involved more</text>
<text top="652" left="57" width="192" height="9" font="0">often in PCNSL (55.6%) than in GBM (18.5%);</text>
<text top="650" left="252" width="5" height="13" font="1">p</text>
<text top="652" left="259" width="31" height="9" font="0">&lt; 0.001.</text>
<text top="664" left="57" width="234" height="9" font="0">Finally, cerebral cortex was affected significantly often in</text>
<text top="676" left="57" width="234" height="9" font="0">GBM (83.3%) than in PCNSL (51.9%); mostly by both</text>
<text top="688" left="57" width="234" height="9" font="0">enhancing and non-enhancing infiltration. In the Table <a href="">4</a></text>
<text top="700" left="57" width="234" height="9" font="0">you can find combinations of several MRI findings and</text>
<text top="712" left="57" width="234" height="9" font="0">their occurrence in both groups. According those find-</text>
<text top="724" left="57" width="234" height="9" font="0">ings we constructed the diagram of the decision tree</text>
<text top="88" left="305" width="234" height="9" font="0">analysis (Fig. <a href="">8). </a>According to Tables <a href="">3 </a>and <a href="">4, </a>major cri-</text>
<text top="100" left="305" width="234" height="9" font="0">teria in decision making process between PCNSL and</text>
<text top="112" left="305" width="234" height="9" font="0">GBM are the type of enhancement and presence or ab-</text>
<text top="124" left="305" width="234" height="9" font="0">sence of necrosis. As minor criteria we considered basal</text>
<text top="136" left="305" width="234" height="9" font="0">ganglia and optic pathways affections, signs of bleeding,</text>
<text top="148" left="305" width="234" height="9" font="0">both supratentorial and infratentorial localization and</text>
<text top="160" left="305" width="132" height="9" font="0">diffuse infiltrative type of lesion.</text>
<text top="184" left="305" width="48" height="9" font="2">Discussion</text>
<text top="196" left="305" width="234" height="9" font="0">In the present study, we compared morphological MRI</text>
<text top="208" left="305" width="234" height="9" font="0">characteristics in PCNSL and GBM at time of initial</text>
<text top="220" left="305" width="234" height="9" font="0">MRI. At initial evaluation, PCNSL lesions were pre-</text>
<text top="232" left="305" width="234" height="9" font="0">sented as multiple infiltrative lesions, which enhanced</text>
<text top="244" left="305" width="234" height="9" font="0">homogenously or as diffuse infiltrative affection of the</text>
<text top="256" left="305" width="234" height="9" font="0">brain. GBM typically manifested as a supratentorial soli-</text>
<text top="268" left="305" width="234" height="9" font="0">tary infiltrative tumor nearly in all cases nonhomoge-</text>
<text top="280" left="305" width="234" height="9" font="0">neous enhancement was present with evident necrosis.</text>
<text top="292" left="305" width="234" height="9" font="0">Both GBM and PCNSL lesions reached the surface of</text>
<text top="304" left="305" width="234" height="9" font="0">the brain in most cases; meningeal and ependymal infil-</text>
<text top="316" left="305" width="114" height="9" font="0">tration was not uncommon.</text>
<text top="328" left="313" width="226" height="9" font="0">We detected several significant differences between</text>
<text top="340" left="305" width="234" height="9" font="0">PCNSL and GBM lesions. The most striking difference</text>
<text top="352" left="305" width="234" height="9" font="0">was in enhancement patterns; while homogeneous en-</text>
<text top="364" left="305" width="234" height="9" font="0">hancement was not detected in GBM, most PCNSL le-</text>
<text top="376" left="305" width="234" height="9" font="0">sions (64.8%) enhanced homogeneously. Additionally,</text>
<text top="388" left="305" width="234" height="9" font="0">necrosis was observed in most GBM lesions (88.9%) but</text>
<text top="400" left="305" width="234" height="9" font="0">was rare in PCNSL (5.6%). Optic pathways infiltration</text>
<text top="412" left="305" width="234" height="9" font="0">was common in PCNSL and rare in GBM. Other cranial</text>
<text top="424" left="305" width="234" height="9" font="0">nerves infiltrations were not frequent and were found</text>
<text top="436" left="305" width="234" height="9" font="0">only in PCNSL (5.6%). Signs of bleeding were rare in</text>
<text top="448" left="305" width="234" height="9" font="0">PCNSL and common in GBM. The basal ganglia in-</text>
<text top="460" left="305" width="234" height="9" font="0">volvement occurred more frequently in PCNSL than in</text>
<text top="472" left="305" width="234" height="9" font="0">GBM. Diffuse infiltrative type of brain involvement was</text>
<text top="484" left="305" width="234" height="9" font="0">observed only in PCNSL (24.1%) and also only PCNSL</text>
<text top="496" left="305" width="234" height="9" font="0">was localized both supratentorial and infratentorial</text>
<text top="508" left="305" width="234" height="9" font="0">(27.7%). Finally, cerebral cortex was affected significantly</text>
<text top="520" left="305" width="234" height="9" font="0">often in GBM (83.3%) than in PCNSL (51.9%); mostly by</text>
<text top="532" left="305" width="234" height="9" font="0">both enhancing and non-enhancing tumorous infiltra-</text>
<text top="544" left="305" width="234" height="9" font="0">tion. Solitary non-enhancing tumorous affection of</text>
<text top="556" left="305" width="206" height="9" font="0">cerebral cortex in both diagnoses was uncommon.</text>
<text top="568" left="313" width="226" height="9" font="0">Our MRI findings in GBM are in agreement with</text>
<text top="580" left="305" width="234" height="9" font="0">those reported previously <a href="">[17]. </a>However, our findings in</text>
<text top="592" left="305" width="234" height="9" font="0">PCNSL are only partially consistent with those reported</text>
<text top="604" left="305" width="234" height="9" font="0">by Haldorsen et al. <a href="">[18]. </a>In the present study, immuno-</text>
<text top="616" left="305" width="234" height="9" font="0">competent PCNSL patients presented with multiple le-</text>
<text top="628" left="305" width="234" height="9" font="0">sions in 51.9% of cases, and with involvement of the</text>
<text top="640" left="305" width="234" height="9" font="0">basal ganglia in 55.6% cases. In contrast, Haldorsen et al.</text>
<text top="652" left="305" width="234" height="9" font="0">reported multiple lesions in only 35% of PCNSL cases,</text>
<text top="664" left="305" width="234" height="9" font="0">with basal ganglia involvement in 32% of cases <a href="">[18].</a></text>
<text top="676" left="305" width="234" height="9" font="0">However, they also reported disseminating lesions in 7%</text>
<text top="688" left="305" width="234" height="9" font="0">of cases <a href="">[18]. </a>In our study we used category diffused in-</text>
<text top="700" left="305" width="234" height="9" font="0">filtrative affection and probably this category is equal to</text>
<text top="712" left="305" width="234" height="9" font="0">HaldorsenÂ´s disseminating lesions. We found diffuse in-</text>
<text top="724" left="305" width="234" height="9" font="0">filtrative brain affection by PCNSL in 24.1% of cases.</text>
<text top="341" left="63" width="20" height="7" font="3">Fig. 3</text>
<text top="341" left="85" width="164" height="7" font="4">PCNSL. The involvement of the right optic chiasma</text>
<text top="33" left="57" width="30" height="7" font="5">Malikova</text>
<text top="31" left="89" width="70" height="9" font="6">et al. Cancer Imaging</text>
<text top="32" left="161" width="44" height="9" font="7"> (2016) 16:40 </text>
<text top="33" left="496" width="43" height="7" font="5">Page 6 of 11</text>
</page>
</pdf2xml>
